Merck & Co., Inc.
IDVYNSO
HIV-1
Resolved
68days ago
Approval decision · Apr 30, 2026
What's at stake
A final FDA approval decision on IDVYNSO for HIV-1 is expected Apr 30, 2026.
Primary source
· SEC 8-K
verified 15h ago
“Received U.S. FDA Approval for IDVYNSO, a Once-Daily, Oral Treatment for Certain Adults With Virologically Suppressed HIV-1”